U.S., May 31 -- ClinicalTrials.gov registry received information related to the study (NCT06995976) titled 'Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73' on May 21.
Brief Summary: As a new CD73-targeted PET radiotracer, 68Ga-dPNE, is promising as an excellent imaging agent applicable to various cancers. In this study, we observed the safety, biodistribution and radiation dosimetry of 68Ga-dPNE in human volunteers. Furthermover, we conducted a comparative analysis of 68Ga-dPNE and 18F-FDG imaging to assess both the radiation dosimetry and diagnostic efficacy of 68Ga-dPNE.
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Malignant Tumour
Intervention:
DRUG: 68Ga-dPNE
Intravenous ...